MARC details
000 -LEADER |
fixed length control field |
04762cam a2200589 i 4500 |
001 - CONTROL NUMBER |
control field |
ocn837578458 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240729131132.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
fixed length control field |
m d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr ||||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
120402s2012 nyua ob 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2019714376 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
019 ## - |
-- |
923664914 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
9781620816295 |
Qualifying information |
ebook |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
1620816296 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
9781620815809 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
162081580X |
Qualifying information |
(hbk.) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
541277 |
-- |
(N$T) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)837578458 |
Canceled/invalid control number |
(OCoLC)923664914 |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WJ 300 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
055000 |
Source |
bisacsh |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
MAIN |
245 00 - TITLE STATEMENT |
Title |
Nephropathy : |
Subtitle |
diagnosis and treatment |
Statement of responsibility, etc |
|
Medium |
[E-Book] |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
New York : |
Name of producer, publisher, distributor, manufacturer |
Nova Biomedical, |
Date of production, publication, distribution, manufacture, or copyright notice |
[2012] |
300 ## - PHYSICAL DESCRIPTION |
Physical description |
1 online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
490 1# - SERIES TITLE |
Series statement |
Nephrology research and clinical developments |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 0# - CONTENTS |
Contents |
NEPHROPATHY: DIAGNOSIS AND TREATMENT; NEPHROPATHY: DIAGNOSIS AND TREATMENT; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: ACUTE KIDNEY INJURY; INTRODUCTION; AKI DEFINITION; AKI ETIOLOGY AND PATHOBIOLOGY; Prerenal Azotemia; Ischemic and Nephrotoxic Acute Tubular Necrosis; Contrast Induced Nephropathy (CIN) (See also Chapter 16); Drug Induced AKI; Amininoglycoside Nephrotoxicity; Tumor Lysis; Rhabdomyolysis; Cast Nephropathy and AKI; Septic AKI; Early Biomarkers of AKI; Serum Biomarkers; Serum Cystatin C; Pro-Atrial Natriuretic Polypeptide (Proanp) |
505 8# - CONTENTS |
Contents |
Urinary BiomarkersNeutrophil Gelatinase Associated Lipocalin (NGAL); Kidney Injury Molecule -- 1 (KIM-1); Urinary Na+ -- H+ Exchanger Isoform 3 (NHE3); Urinary Cytokines; Cysteine Rich Protein 61 (Cyr61, CCN1); Glutathione S-Transferases (GSTs); Hepatocyte Growth Factor (HGF); Epidermal Growth Factor (EGF); Insulin Like Growth Factor -- 1 (IGF-1); AKI SECONDARY TO ACUTE TUBULOINTERSTITAL NEPHRITIS; AKI SECONDARY TO ACUTE GLOMEURLONEPHRITISAND VASCULITIS; AKI FROM ACUTE OBSTRUCTION; GPAKI IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION; TROPICAL INFECTIONS AND AKI; Falciparum Malaria. |
505 8# - CONTENTS |
Contents |
LeptospirosisMANAGEMENT OF AKI; Fluid Resuscitation in AKI; Loop Diuretics in AKI; Role of Dopamine and Fenoldapam in AKI; RENAL REPLACEMENT THERAPY IN AKI; Vascular Access for Renal Replacement Therapy; Conventional Intermittent Hemodialysis (IHD); Dialysis Dose in IHD; Continuous Renal Replacement Therapy (CRRT); Comparing IHD Versus CRRT for AKI Support; Dialysis Dosing in CRRT; Sustained Low Efficiency Dilaysis; CONCLUSION; REFERENCES; Chapter 2: IDENTIFICATION AND EVALUATION OFPATIENTS WITH CHRONIC KIDNEY DISEASE; INTRODUCTION; DEFINING CHRONIC KIDNEY DISEASE. |
505 8# - CONTENTS |
Contents |
CAUSES OF CHRONIC KIDNEY DISEASEDiseases of the Arterial Supply; Glomerular Diseases; Tubulo-Interstitial Diseases; Obstructive Uropathy; The Diagnosis of 'CKD -- Cause Unknown'; Relative Incidences of Causes of CKD; MEASURING KIDNEY FUNCTION; MDRD Formula to Estimate GFR; CKD-EPI Formulae; Cockcroft Gault Formula; Cystatin C; EXAMINATION OF THE URINE; Urinalysis; Protein; Haem; Urine Microscopy; Laboratory Quantification of Proteinuria; PRESENTATION OF CKD; Asymptomatic Reduced eGFR and/or Proteinuria; Nephrotic Syndrome; Nephritic Syndrome; Isolated Non-Visible Haematuria. |
505 8# - CONTENTS |
Contents |
CKD Following Acute Kidney InjuryAdvanced Uraemia; EVALUATION OF THE PATIENT WITH CKD; History; Examination; Kidney Imaging (See also Chapter 3); Specific Blood Tests; Kidney Biopsy (See also Chapter 6); GRADING/CLASSIFICATION OF CKD; REFERENCES; Chapter 3: IMAGING IN KIDNEY DISEASE; INTRODUCTION; IMAGING TECHNIQUES; Ultrasound; Computed Tomography; Magnetic Resonance Imaging; Renal Scintigraphy; Plain Radiography; Intravenous Urography; The Impact of Obesity on Medical Imaging; Image Guided Renal Biopsy; ACUTE KIDNEY INJURY (AKI); Introduction; Pre-Renal AKI; Post-Renal AKI; Intrinsic AKI. |
590 ## - LOCAL NOTE (RLIN) |
Local note |
Master record variable field(s) change: 050, 082, 650 |
650 #0 - SUBJECT HEADINGS |
Subject term |
Kidneys |
General subdivision |
Diseases. |
650 #2 - SUBJECT HEADINGS |
Subject term |
Kidney Diseases |
General subdivision |
diagnosis. |
650 #2 - SUBJECT HEADINGS |
Subject term |
Kidney Diseases |
General subdivision |
therapy. |
700 1# - ADDED PERSONAL NAME |
Added personal author |
Fava, Stephen, |
Relator term |
editor of compilation. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Nephrology research and clinical developments series. |
856 ## - ONLINE RESOURCE |
Uniform Resource Identifier |
<a href="#gotoholdings">#gotoholdings</a> |
Link text |
Access resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Suppress in OPAC |
Do not Suppress in OPAC |
588 ## - SOURCE OF DESCRIPTION NOTE |
Source of description note |
Description based on print version record. |
938 ## - |
-- |
YBP Library Services |
-- |
YANK |
-- |
9370070 |
938 ## - |
-- |
EBSCOhost |
-- |
EBSC |
-- |
541277 |
938 ## - |
-- |
ebrary |
-- |
EBRY |
-- |
ebr10681186 |
938 ## - |
-- |
ProQuest Ebook Central |
-- |
EBLB |
-- |
EBL3020986 |
994 ## - |
-- |
92 |
-- |
N$T |